Considerations on manganese (Mn) treatments for in vitro studies

NeuroToxicology

Volumn 41, Issue , 2014, Pages 141-142

  Bowman, Aaron B ^a   Aschner, Michael ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain concentrations; In vitro; Manganese; Toxicity

Indexed keywords

MANGANESE;

ARTICLE; BASAL GANGLION; BRAIN LEVEL; BRAIN REGION; CELL LEVEL; CELL LOSS; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL EXPOSURE; EXTRAPYRAMIDAL SYNDROME; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TOXICOKINETICS;

BRAIN CONCENTRATIONS; IN VITRO; MANGANESE; TOXICITY;

ANIMALS; BRAIN; HUMANS; MANGANESE; MANGANESE POISONING;

EID: 84895148713     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.01.010     Document Type: Article

References (16)

1. Bowman A.B., Kwakye G.F., Herrero Hernández E., Aschner M. Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol 2011, 25(4):191-203.
2. Császma I., Andrási E., Lásztity A., Bertalan E., Gawlik D. Determination of Mo and Mn in human brain samples by different techniques. J Anal At Spectrom 2003, 18:1082-1087.
3. Calne D.B., Chu N.S., Huang C.C., Lu C.S., Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994, 44:1583-1586.
4. Cersosimo M.G., Koller W.C. The diagnosis of manganese-induced parkinsonism. NeuroToxicology 2006, 27:340-346.
5. Criswell S.R., Perlmutter J.S., Videen T.O., Moerlein S.M., Flores H.P., Birke A.M., et al. Reduced uptake of [(18)F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology 2011, 76:1296-1301.
6. Erikson K.M., Dorman D.C., Lash L.H., Aschner M. Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci 2007, 97:459-466.
7. Gorell J.M., Peterson E.L., Rybicki B.A., Johnson C.C. Multiple risk factors for Parkinson's disease. J Neurol Sci 2004, 217:169-174.
8. Guilarte T.R. Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect 2010, 118:1071-1080.
9. Hudnell H.K. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. Neurotoxicology 1999, 20:379-397.
10. Madison J.L., Wegrzynowicz M., Aschner M., Bowman A.B. Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLoS ONE 2012, 7(2):e31024.
11. Matthews B.W. Determination of molecular weight from protein crystals. J Mol Biol 1974, 82:513-526.
12. Molina R.M., Phattanarudee S., Kim J., Thompson K., Wessling-Resnick M., Maher T.J., et al. Ingestion of Mn and Pb by rats during and after pregnancy alters iron metabolism and behavior in offspring. Neurotoxicology 2011, 32:413-422.
13. Newland M.C., Ceckler T.L., Kordower J.H., Weiss B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989, 106:251-258.
14. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci 2004, 1012:209-223.
15. Racette B.A., Tabbal S.D., Jennings D., Good L., Perlmutter J.S., Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 2005, 64:230-235.
16. Williams B.B., Li D., Wegrzynowicz M., Vadodaria B.K., Anderson J.G., Kwakye G.F., et al. Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J Neurochem 2010, 112(1):227-237.